what is tirzepatide and semaglutide vs Tirzepatide vs. Semaglutide: Which Is
Description
Ismaeil A, Babiker F, Al-Sabah S
Among those who no longer took the GLP-1, 82 percent who lost weight regained 25 percent or more of their initial weight loss within a year of stopping the drug
Generic versions are not yet available but may emerge in the future after patent expiry
Related Stories Weight loss drugs may reduce binge eating disorder symptoms Nine gut bacteria linked to future type 2 diabetes risk Popular diabetes drugs do not alter the risk of developing a blinding eye condition The ongoing SURMOUNT trials confirm the results of the SURPASS trials
Zepbound was also approved in December 2024 for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity [9]
